Adenosine promotes alternative macrophage activation via A2A and A2B receptors

Adenosine has been implicated in suppressing the proinflammatory responses of classically activated macrophages induced by Th1 cytokines. Alternative macrophage activation is induced by the Th2 cytokines interleukin (IL)‐4 and IL‐13; however, the role of adenosine in governing alternative macrophage activation is unknown. We show here that adenosine treatment of IL‐4‐ or IL‐13‐activated macrophages augments the expression of alternative macrophage markers arginase‐1, tissue inhibitor of matrix metalloproteinase‐1 (TIMP‐1), and macrophage galactose‐type C‐type lectin‐1. The stimulatory effect of adenosine required primarily A2B receptors because the nonselective adenosine receptor agonist 5'‐N ‐ethylcarboxamidoadenosine (NECA) increased both arginase activity (EC50=261.8 nM) and TIMP‐1 production (EC50=80.67 nM), and both pharmacologic and genetic blockade of A2B receptors prevented the effect of NECA. A2A receptors also contributed to the adenosine augmentation of IL4‐induced TIMP‐1 release, as both adenosine and NECA were less efficacious in augmenting TIMP‐1 release by A2A receptor‐deficient than control macrophages. Of the transcription factors known to drive alternative macrophage activation, CCAAT‐enhancer‐binding protein β was required, while cAMP response element‐binding protein and signal transducer and activator of transcription 6 were dispensable in mediating the effect of adenosine. We propose that adenosine receptor activation suppresses inflammation and promotes tissue restitution, in part, by promoting alternative macrophage activation. Csóka, B., Selmeczy, Z., Koscsó, B., Németh, Z. H., Pacher, P., Murray, P. J., Kepka‐Lenhart, D., Morris S. M., Jr., Gause, W. C., Leibovich, S. J., Haskó, G. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J. 26, 376–386 (2012). www.fasebj.org

[1]  Jeffrey M. Wilson,et al.  The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells 1 , 2009, The Journal of Immunology.

[2]  J. Schittenhelm,et al.  Cutting Edge: A2B Adenosine Receptor Signaling Provides Potent Protection during Intestinal Ischemia/Reperfusion Injury1 , 2009, The Journal of Immunology.

[3]  U. Yamashita,et al.  Reduced expression of STAT4 and IFN-gamma in macrophages from BALB/c mice. , 2002, Journal of immunology.

[4]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[5]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[6]  Pál Pacher,et al.  Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.

[7]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[8]  M. Koupenova,et al.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. , 2006, The Journal of clinical investigation.

[9]  Dan Yang,et al.  Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury. , 2009, Experimental hematology.

[10]  M. Mirabet,et al.  IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. , 1999, Journal of immunology.

[11]  G. Kaplan,et al.  Arginine Usage in Mycobacteria-Infected Macrophages Depends on Autocrine-Paracrine Cytokine Signaling , 2010, Science Signaling.

[12]  P. De Baetselier,et al.  Alternatively activated macrophages during parasite infections. , 2004, Trends in parasitology.

[13]  K. Jacobson,et al.  Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.

[14]  J. Albina,et al.  MACROPHAGE ARGINASE REGULATION BY CCAAT/ENHANCER-BINDING PROTEIN β , 2005, Shock.

[15]  W. Calhoun,et al.  Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[16]  M. Blackburn,et al.  Adenosine receptors and inflammation. , 2009, Handbook of experimental pharmacology.

[17]  Kyu-Earn Kim,et al.  Upregulation of MUC5AC gene expression by IL‐4 through CREB in Human airway epithelial cells , 2009, Journal of cellular biochemistry.

[18]  E. Vizi,et al.  A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. , 2007, Blood.

[19]  B. Sperlágh,et al.  Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism. , 2004, Biochemical and biophysical research communications.

[20]  E. Vizi,et al.  Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. , 1996, Journal of immunology.

[21]  N. Rosenthal,et al.  A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair , 2009, Proceedings of the National Academy of Sciences.

[22]  U. Yamashita,et al.  Reduced Expression of STAT4 and IFN-γ in Macrophages from BALB/c Mice1 , 2002, The Journal of Immunology.

[23]  E. Vizi,et al.  A2B Adenosine Receptors Protect against Sepsis-Induced Mortality by Dampening Excessive Inflammation , 2010, The Journal of Immunology.

[24]  M. Pelletier,et al.  Molecular mechanisms involved in interleukin‐4‐induced human neutrophils: expression and regulation of suppressor of cytokine signaling , 2007, Journal of leukocyte biology.

[25]  E. Vizi,et al.  A(2B) adenosine receptors in immunity and inflammation. , 2009, Trends in immunology.

[26]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[27]  S. Morris,et al.  Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. , 2005, Gene.

[28]  G. Kaplan,et al.  Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens , 2008, Nature Immunology.

[29]  M. Sitkovsky,et al.  Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. , 2005, Nature reviews. Immunology.

[30]  Z. Ge,et al.  Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.

[31]  G. Freund,et al.  IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCdelta. , 2004, Cellular signalling.

[32]  D. Mullins,et al.  Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.

[33]  B. Dahal,et al.  Macrophage galactose‐type C‐type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation , 2005, Journal of leukocyte biology.

[34]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[35]  M. Munder,et al.  Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. , 1998, Journal of immunology.

[36]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[37]  B. Foxwell,et al.  IL-4 regulation of p38 MAPK signalling is dependent on cell type. , 2002, Cytokine.

[38]  S. Vogel,et al.  An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.

[39]  I Biaggioni,et al.  Adenosine A2B receptors. , 1997, Pharmacological reviews.

[40]  M. Caldwell,et al.  Temporal expression of different pathways of 1-arginine metabolism in healing wounds. , 1990, Journal of immunology.

[41]  W. Gause,et al.  Alternatively activated macrophages in helminth infections. , 2007, Current opinion in immunology.

[42]  I. Biaggioni,et al.  Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. , 1999, Molecular pharmacology.

[43]  Atique U. Ahmed,et al.  Macrophages orchestrate the immune response to tumor cell death. , 2001, Cancer research.

[44]  E. Vizi,et al.  Role of A2A adenosine receptors in regulation of opsonized E. coli-induced macrophage function , 2007, Purinergic Signalling.

[45]  I. Biaggioni,et al.  Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. , 1993, Molecular pharmacology.

[46]  J. Linden Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[47]  E. Deitch,et al.  Adenosine inhibits IL-12 and TNF-a production via adenosine A 2 a receptor-dependent and independent mechanisms , 2000 .

[48]  A. Ohta,et al.  A2B Adenosine Receptor Blockade Enhances Macrophage-Mediated Bacterial Phagocytosis and Improves Polymicrobial Sepsis Survival in Mice , 2011, The Journal of Immunology.

[49]  E. Vizi,et al.  Shaping of monocyte and macrophage function by adenosine receptors. , 2007, Pharmacology & therapeutics.

[50]  P. Murray,et al.  Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression1 , 2004, The Journal of Immunology.

[51]  M. Modolell,et al.  Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. , 1995, Biochemical and biophysical research communications.

[52]  C. Szabó,et al.  ADENOSINE STIMULATES CREB ACTIVATION IN MACROPHAGES VIA A P38 MAPK‐MEDIATED MECHANISM: 165 , 2003 .

[53]  Geert Raes,et al.  Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. , 2006, Immunobiology.

[54]  John S. Welch,et al.  TH2 Cytokines and Allergic Challenge Induce Ym1 Expression in Macrophages by a STAT6-dependent Mechanism* , 2002, The Journal of Biological Chemistry.

[55]  E. Vizi,et al.  Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism1 , 2005, The Journal of Immunology.

[56]  T. Wynn,et al.  Obstacles and opportunities for understanding macrophage polarization , 2011, Journal of leukocyte biology.

[57]  I. Biaggioni,et al.  Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory Cytokines , 2008, Journal of Pharmacology and Experimental Therapeutics.

[58]  I. Biaggioni,et al.  Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. , 1998, Biochemical pharmacology.